首页> 外文期刊>Pharmacological research: The official journal of The Italian Pharmacological Society >CKIP-1 acts downstream to Cx43 on the activation of Nrf2 signaling pathway to protect from renal fibrosis in diabetes
【24h】

CKIP-1 acts downstream to Cx43 on the activation of Nrf2 signaling pathway to protect from renal fibrosis in diabetes

机译:CKIP-1对CX43的下游作用于NRF2信号通路的激活,以保护糖尿病中的肾纤维化

获取原文
获取原文并翻译 | 示例
       

摘要

We previously reported that both Cx43 and CKIP-1 attenuated diabetic renal fibrosis via the activation of Nrf2 signaling pathway. However, whether CKIP-1, a scaffold protein, participates in regulating the activation of Nrf2 signaling pathway by Cx43 remains to be elucidated. In this study, the effect of adenovirus-mediated Cx43 overexpression on renal fibrosis in CKIP-1(-/-) diabetic mice was investigated. We found that overexpression of Cx43 could significantly alleviate renal fibrosis by activating the Nrf2 pathway in diabetic mice, but have no obvious effect in CKIP-1(-/-) diabetic mice. Cx43 overexpressed plasmid and CKIP-1 small interfering RNA were simultaneously transfected into glomerular mesangial cells and the result demonstrated that the effect of activation of Nrf2 signaling pathway by Cx43 was blocked by CKIP-1 depletion. The interaction between Cx43 and CKIP-1 was analyzed by immunofluorescence and immunoprecipitation assays. We found that Cx43 interacted with CKIP-1, and the interaction was weakened by high glucose treatment. Moreover, Cx43 regulated the expression of CKIP-1 and the interaction of CKIP-1 with Nrf2 via Cx43 carboxyl terminus (CT) domain, thereby activating Nrf2 signaling pathway. According to the results, we preliminary infer that CKIP-1 acts downstream to CX43 on the activation of Nrf2 signaling pathway to protect from renal fibrosis in diabetes, the mechanism of which might be related to the interaction of CKIP-1 with Nrf2 through Cx43 CT. Our study provides further experimental basis for targeting the Cx43-CKIP-1-Nrf2 axis to resist diabetic renal fibrosis.
机译:我们之前报道过,Cx43和CKIP-1都通过激活Nrf2信号通路来减轻糖尿病肾纤维化。然而,支架蛋白CKIP-1是否通过Cx43参与调节Nrf2信号通路的激活仍有待阐明。在本研究中,研究了腺病毒介导的Cx43过度表达对CKIP-1(-/-)糖尿病小鼠肾纤维化的影响。我们发现,在糖尿病小鼠中,Cx43的过度表达可以通过激活Nrf2途径显著减轻肾纤维化,但在CKIP-1(-/-)糖尿病小鼠中没有明显效果。将Cx43过表达质粒和CKIP-1小干扰RNA同时转染肾小球系膜细胞,结果表明,CKIP-1缺失阻断了Cx43激活Nrf2信号通路的作用。通过免疫荧光和免疫沉淀分析Cx43和CKIP-1之间的相互作用。我们发现Cx43与CKIP-1相互作用,并且这种相互作用被高糖治疗削弱。此外,Cx43通过Cx43羧基末端(CT)结构域调节CKIP-1的表达以及CKIP-1与Nrf2的相互作用,从而激活Nrf2信号通路。根据这些结果,我们初步推断CKIP-1在CX43下游对Nrf2信号通路的激活起作用,以保护糖尿病患者的肾纤维化,其机制可能与CKIP-1通过CX43-CT与Nrf2的相互作用有关。我们的研究为靶向Cx43-CKIP-1-Nrf2轴抗糖尿病肾纤维化提供了进一步的实验基础。

著录项

  • 来源
  • 作者单位

    Sun Yat Sen Univ Sch Pharmaceut Sci Lab Pharmacol &

    Toxicol Guangzhou 510006 Peoples R China;

    Guangdong Second Prov Gen Hosp Med Res Ctr Guangzhou Peoples R China;

    Natl Ctr Prot Sci Skate Key Lab Prote Beijing 100850 Peoples R China;

    Sun Yat Sen Univ Sch Pharmaceut Sci Lab Pharmacol &

    Toxicol Guangzhou 510006 Peoples R China;

    Sun Yat Sen Univ Sch Pharmaceut Sci Lab Pharmacol &

    Toxicol Guangzhou 510006 Peoples R China;

    Sun Yat Sen Univ Sch Pharmaceut Sci Lab Pharmacol &

    Toxicol Guangzhou 510006 Peoples R China;

    Sun Yat Sen Univ Sch Pharmaceut Sci Lab Pharmacol &

    Toxicol Guangzhou 510006 Peoples R China;

    Sun Yat Sen Univ Sch Pharmaceut Sci Lab Pharmacol &

    Toxicol Guangzhou 510006 Peoples R China;

    Sun Yat Sen Univ Sch Pharmaceut Sci Lab Pharmacol &

    Toxicol Guangzhou 510006 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学;
  • 关键词

    Diabetic nephropathy; Oxidative stress; Cx43; CKIP-1; Nrf2;

    机译:糖尿病肾病;氧化应激;CX43;CKIP-1;NRF2;
  • 入库时间 2022-08-20 18:59:46

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号